Yizhe Wu

Title: Yizhe Wu and a Casein Kinase 1ε Inhibitor Crystal Form.

Introduction

Yizhe Wu is an inventor based in Hangzhou, China. His patent work includes a crystal form of a casein kinase 1ε inhibitor, along with methods for preparing and using it.

Latest Patents

Wu is associated with 1 patent: “Crystal Form of Casein Kinase 1ε Inhibitor and Preparation Method and Use Thereof.” The patent describes a crystal form of the compound (S)-2-(1-(4-amino-3-(2,3-difluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-3-phenylquinazoline-4(3H)one methanesulfonate. According to the disclosure, the crystal form has good water solubility and oral absorption. It may support treatment of malignant tumors and autoimmune diseases that benefit from inhibiting casein kinase 1ε activity.

Career Highlights

Wu is associated with Hangzhou Healzen Therapeutics Co., Ltd. His patent work focuses on the crystal form, preparation, and potential therapeutic use of a casein kinase 1ε inhibitor.

Collaborations

The provided information lists Xinglu Zhou and Xingguo Liu as Wu’s coworkers. It does not specify their roles in the patent or the extent of their collaboration.

Conclusion

Yizhe Wu’s disclosed patent centers on a potentially useful crystal form of a casein kinase 1ε inhibitor, with reported solubility and oral absorption properties relevant to its proposed therapeutic applications.